Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
about
The Role of PARP Inhibitors in the Treatment of Gynecologic MalignanciesEnhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsPredictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized MedicineNuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancerLow-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis.Activation of poly(ADP-ribose) polymerase-1 delays wound healing by regulating keratinocyte migration and production of inflammatory mediators.PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond.PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyLow doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2.Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsRole of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.PARP inhibitors and heart failure--translational medicine caught in the act.Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferationGenomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegenerationDeciphering the insights of poly(ADP-ribosylation) in tumor progression.PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinomaInhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.Molecular pathways: targeting PARP in cancer treatment.LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.Vitamin E improves testicular damage in streptozocin-induced diabetic rats, via increasing vascular endothelial growth factor and poly(ADP-ribose) polymerase-1.Vascular endothelial growth factor confers endothelial resistance to apoptosis through poly(ADP-ribose) polymerase.Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.Parp-1genetic ablation inEla-mycmice unveils novel roles for Parp-1 in pancreatic cancer
P2860
Q21129302-A1186244-F507-4875-8B26-0810D60412FEQ26768267-8A6B9192-48D3-45B1-A06A-B7700CCCA862Q28072204-EBD6D529-4183-4464-863C-EDBB6A686709Q28247712-CB5BE5B3-EC63-4124-AF73-FCE007A47322Q33710801-92C9DA1F-84DC-4D98-BB75-E4F36E39D25EQ34129764-5FFA22E7-D0A1-4B4E-AAB3-EBBD87D2EB26Q34215904-09FE29B5-C9EF-4193-88F7-B37C51862F80Q34670090-3F27968D-4987-400D-90F8-8F7593C28AB6Q35052831-121A855B-2191-4CCF-9B1E-AAB50C6E89C3Q35514172-85B1E474-700E-46FC-BA91-60EBCD569842Q35676514-CF2377A3-3091-4505-9D42-E78E37D88D38Q36144711-3D9E9C46-59E1-4BAB-B313-DDF39ACA3A58Q36387871-AD946B07-19B0-49C5-BC52-A683C828C510Q36416330-55F4A562-1E01-4E90-B070-615A1BFBE111Q36426742-2325CFA3-E032-45BD-ABE5-EF8A0902EC4EQ36734840-159584D4-D5FD-46A9-99B7-E78538B116C3Q36773354-81BB8F4F-4FC7-48CC-BF3B-4A1C13192963Q37105857-7FB5001E-37D4-49B9-9C57-D85D047035F9Q37114252-3D08653A-862E-462A-9C82-665FF86724BAQ37822920-2625CCD2-88F2-494C-853E-F9E7FF21AD3CQ38325685-9F126B0E-C5E0-4084-AEDF-1D0694CAFBDCQ38964488-D946D99E-783F-4E6F-8B03-642171031CABQ39085640-1F246AE1-4629-495A-9F2D-69B66A52292FQ39497723-AA11A3EA-1E33-430C-B54D-501EB0145AC9Q40244416-AC1087AA-9895-48A2-8CE7-EF26D8BD2F95Q48256451-77DD2AEB-A311-4CAB-A14D-32A9896623B2Q50277380-74D6D32C-C62F-49EC-AFB7-7548FA14012DQ51723573-A1095A79-2335-4989-AB29-ADAE1879667FQ59281988-72B079BF-CEF9-452F-87CD-6DF2B9506412
P2860
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@ast
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@en
type
label
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@ast
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@en
prefLabel
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@ast
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@en
P2093
P2860
P1476
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis
@en
P2093
Grzegorz Godlewski
György Haskó
Lucas Liaudet
Mohanraj Rajesh
Sándor Bátkai
P2860
P304
P356
10.1016/J.BBRC.2006.09.049
P407
P577
2006-09-20T00:00:00Z